Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Central Nervous System Neoplasms 4 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Prostatic Neoplasms 2 Head and Neck Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Teratoma 1 Solitary Fibrous Tumor, Pleural 1 Rhabdoid Tumor 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Liposarcoma 1 Leiomyosarcoma 1 Inflammatory Breast Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1

Interventions

Ifosfamide 7 Doxorubicin 7 Trabectedin 3 brostallicin 2 Radiotherapy, Conformal 2 Filgrastim 2 perifosine 1 pegfilgrastim 1 indolepropanol phosphate 1 exatecan 1 X-Rays 1 Watchful Waiting 1 Surgical Procedures, Operative 1 Radiotherapy 1 Observation 1 Neoadjuvant Therapy 1 Mass Spectrometry 1 Imatinib Mesylate 1 Combined Modality Therapy 1 Chromatography, High Pressure Liquid 1 Chemotherapy, Adjuvant 1 Biopsy 1 BI 2536 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Leiomyosarcoma × Neoadjuvant Therapy × Clear all

NCT04031677 2026-05-22

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡